CJC 1295 WITH DAC KITS

Description

CJC-1295 with DAC

CJC-1295 with DAC is a synthetic research peptide studied for its interaction with growth hormone-releasing hormone (GHRH) receptor pathways and its role in peptide-mediated signaling. The addition of DAC (Drug Affinity Complex) is intended to extend its activity profile, making it a subject of interest in laboratory and preclinical research involving endocrine signaling, peptide stability, and molecular response pathways.

Researchers may use CJC-1295 with DAC in controlled experimental settings to examine receptor-binding activity, growth-hormone-related signaling, metabolic pathway interactions, and peptide behavior within research models. Its structure and extended-activity characteristics have made it a commonly studied compound in peptide and hormone-related investigative research.

Research Applications

• GHRH receptor interaction studies
• Endocrine signaling research
• Peptide stability investigations
• Growth-hormone pathway research
• Molecular biology studies
• Experimental peptide analysis

Product Specifications

Compound: CJC-1295 with DAC
Category: Synthetic Research Peptide
Classification: GHRH Analog Research Peptide
Form: Lyophilized Powder
Purity: See Current COA
Use: Research & Analytical Applications

Research Use Only

This product is supplied exclusively for laboratory research and analytical purposes. It is intended for use only by qualified professionals in controlled research environments and is not intended for human or veterinary use, consumption, injection, clinical use, diagnostic procedures, or therapeutic applications.